CD44 variant expression and estrogen receptor status in breast cancer

Breast Cancer Research and Treatment

Volumn 43, Issue 2, 1997, Pages 165-173

  Hole, A Kate ^a   Belkhiri, Abbes ^a   Snell, Linda S ^a   Watson, Peter H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Breast cancer; CD44; Estrogen receptor

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; ANTIGENIC VARIATION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANTIGENS, CD44; BREAST NEOPLASMS; ESTRADIOL; EXONS; GENE EXPRESSION; HUMANS; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030894876     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005797030963     Document Type: Article

References (36)

1. Underhill C: CD44: the hyaluronan receptor. J Cell Sci 103: 293-298, 1992
2. StamEnkovic I, ArufFo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10: 343-348, 1991
3. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313, 1990
4. Thomas L, Byers R, Vink J, Stamenkovic I: CD44H regulates tumor cell migration on hyaluronate-coated substrate. J Cell Biol 118: 971-977, 1992
5. Günthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991
6. Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P, Günthert U: CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res 51: 5292-5297, 1991
7. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340: 1053-1058, 1992
8. Dubik D, Dembinski TC, Shiu RPC: Stimulation of c-myc oncogene expression associated with estrogen induced proliferation of human breast cancer cells. Cancer Res 47:6517-6521, 1987
9. Hiller T, Snell LS, Watson PH: Microdissection/RT-PCR analysis of gene expression in frozen tissue sections. Biotechniques 21: 38-43, 1996
10. Tolg C, Hofmann M, Herrlich P, Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucl Acids Res 21: 1225-1229, 1993
11. Günthert U: CD44: A multitude of isoforms with diverse functions. Curr Topics Micro Immunol 184: 47-63, 1993
12. Watson PH, Safneck R, Le K, Dubik D, Shiu RPC: Relationship of c-myc amplification to progression of breast cancer from in-situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902-907, 1993
13. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991
14. Jackson DG, Buckley J, Bell JI: Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267: 4732-4739, 1992
15. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 898: 12160-12164, 1992
16. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-511, 1996
17. MacKay CR, Terpe J-H, Stauder R, Marston WL, Stark H, Günthert U: Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71-82, 1994
18. Rudy W, Hofmann M, Schwatz-Albiez R, Zoller M, Heider K-H, Ponta H: The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53: 1262-1268, 1993
19. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL, Rosada C: Expression of CD44 in human lung tumors. Cancer Res 54: 1381-1387, 1994
20. Heider K-H, Dämmrich J, Skroch-Angel P, Müller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H: Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53: 4197-4203, 1993
21. Tanabe KK, Ellis LM, Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341: 725-726, 1993
22. Heider K-H, Hofmann M, Horst E, Van den Berg F, Ponta H, Herrlich P, Pals ST: A human homologue of the rat metastasis- associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120: 227-233, 1993
23. Wielenga VJM, Heider K-H, Offerhaus GJ, Adolf GR, Van den Berg FM, Ponta H, Herrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756, 1993
24. Joensuu H, Klemi PJ, Toikkanen S, Jalkancn S: Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol 143: 867-874, 1993
25. Sinn H-P, Heider K-H, Skroch-Angel P, Von Minckwitz G, Kaufmann M, Herrlich P, Ponta P: Human mammary carcinomas express homologues of rat metastatis-associated variants of CD44. Breast Cancer Res Treat 36: 307-313, 1995
26. Kaufmann M, Heider K-H, Sinn H-P, Minkwitz G, Ponta H, Herrlich P: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995
27. Friedrichs K, Franke F, Lisboa B-J, Kugler G, Gille I, Terpe H-J, Holzel F, Maas H, Günthert U: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Res 55: 5424-5433, 1995
28. Dall P, Heider K-H, Sinn H-P, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60: 471-477, 1995
29. Edelman GM: A golden age for adhesion. Cell Adhesion Communication 1: 1-7, 1993
30. Takeichi M: Cadherin cell adhesion receptors as a morpho-genetic regulator. Science 251: 1451-1455, 1991
31. Koch PJ, Goldschmidt MD, Zimbelmann R, Troyanovsky R, Franke WW: Complexity and expression patterns of the desmosomal cadherins. Proc Natl Acad Sci USA 89: 353-357, 1992
32. Chaudhry A, Gobi A, Eriksson B, Skogseid B, Öberg K: Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. Cancer Res 54: 981-986, 1994
33. Ghaffari S, Dougherty GJ, Lansdorp PW, Eaves AC, Eaves CJ: Differentiation associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukaemia. Blood 86: 2976-2985, 1995
34. Bae S-N, Arand G, Azzam H, Pavasant P, Torri J, Frandsen TL, Thompson EW: Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 24: 241-255, 1993
35. Clarke R, Thompson EW, Leonessa F, Lippman MS, McGarvey MS, Frandsen TL, Brünner N: Hormone resistance, invasiveness. and metastatic potential in breast cancer. Breast Cancer Res Treat 24: 227-239, 1993
36. Price JE, Polyzos A, Zhang RD, Daniels LM: Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717-721, 1990